TCP III Certification: Market access in Taiwan
Secure a stronger position in Taiwan’s medical device market with DNV’s TCP III Certification, enabling faster, cost-effective compliance through coordinated EU–Taiwan conformity assessments.
TCP III Certification: Market access in Taiwan
DNV offers TCP III Certification, your gateway to medical device compliance and market entry in Taiwan. Under the Technical Cooperation Programme III (TCP III), DNV is officially recognized as a designated conformity assessment body, enabling seamless acceptance of audit results between Taiwan and the EU.
Why TCP III matters
TCP III eliminates the burden of duplicate audits by mutually recognizing inspection outcomes – saving time, reducing cost, and accelerating your entry into Taiwan’s fast-growing medical device market.
What We Offer
Conformity audits: Conduct approval audits to demonstrate compliance with Taiwan’s regulatory standards.
Mutual recognition: Leverage EU-based conformity results for Taiwan approval, no need for repeat audits.
Regulatory guidance: Help navigate complex TCP III requirements and streamline submission.
Global support: Benefit from DNV’s worldwide technical capabilities and accredited oversight.
Why choose DNV?
With over 160 years of assurance expertise across sectors, including medical device, DNV offers credibility, deep insight, and technical excellence. As a recognized TCP III auditor, we empower you to:
- Simplify compliance with coordinated EU–Taiwan audits.
- Leverage our global network and hands-on support.
- Minimize regulatory hurdles and optimize market access.
